| |
FP score ≤ median (n = 57)
|
FP score > median (n = 56)
|
p
|
DE score ≤ median (n = 57)
|
DE score > median (n = 56)
|
p
|
|---|
|
Risk factors
| | | | | | |
|
Age (years)
|
56 (48–69)
|
56 (49–68)
|
0.66
|
56 (51–68)
|
57 (48–68)
|
0.98
|
|
Male
|
43 (75)
|
48 (86)
|
0.25
|
44 (77)
|
47 (84)
|
0.51
|
|
BMI (kg/m2)
|
25 (24–28)
|
26 (24–28)
|
0.35
|
25 (24–29)
|
25 (24–28)
|
0.54
|
|
Hypertension
|
25 (44)
|
16 (29)
|
0.14
|
22 (39)
|
19 (34)
|
0.75
|
|
Diabetes
|
5 (9)
|
7 (12)
|
0.74
|
6 (11)
|
6 (11)
|
0.79
|
|
Hypercholesterolemia
|
19 (33)
|
23 (41)
|
0.51
|
23 (40)
|
19 (34)
|
0.61
|
|
Smoking
|
23 (40)
|
29 (52)
|
0.30
|
22 (39)
|
30 (54)
|
0.42
|
|
Previous PCI or CABG
|
2 (4)
|
2 (4)
|
1.00
|
3 (5)
|
1 (2)
|
0.62
|
|
Peripheral arterial disease
|
2 (4)
|
2 (4)
|
1.00
|
2 (4)
|
2 (4)
|
1.00
|
|
Biological data
| | | | | | |
|
Hyperglycemia (≥ 7.8 mmol/l)
|
17 (30)
|
35 (63)
|
<0.001
|
16 (28)
|
36 (64)
|
<0.001
|
|
Glycemia (mmol/l)
|
7.0 (6.1–8.4)
|
8.4 (6.9–9.7)
|
0.001
|
6.9 (5.9–8.2)
|
8.4 (7.0–9.6)
|
<0.001
|
|
HbA1c (%)
|
5.4 (5.2–5.7)
|
5.7 (5.4–6.3)
|
0.01
|
5.5 (5.2–5.7)
|
5.7 (5.4–6.3)
|
0.04
|
|
Peak CK >10 fold UNL
|
21 (37)
|
45 (80)
|
<0.001
|
17 (30)
|
49 (88)
|
<0.001
|
|
CRP (mg/l)
|
2.2 (1.7–10.0)
|
4.6 (2.0–11.0)
|
0.48
|
2.5 (2.0–11.0)
|
4.7 (2.0–9.0)
|
0.81
|
|
Creatinine clearance (ml/mn)
|
87 (73–116)
|
92 (75–111)
|
0.48
|
92 (74–117)
|
88 (72–111)
|
0.77
|
|
HDL-Cholesterol (mmol/l)
|
1.04 (0.91–1.33)
|
1.17 (0.96–1.41)
|
0.15
|
1.08 (0.91–1.33)
|
1.17 (0.94–1.34)
|
0.50
|
|
LDL-Cholesterol (mmol/l)
|
2.99 (2.49–3.73)
|
3.01 (2.49–3.90)
|
0.74
|
2.93 (2.47–3.79)
|
3.19 (2.56–3.84)
|
0.54
|
|
Triglyceride (mmol/l)
|
1.42 (0.92–2.5)
|
1.29 (0.97–1.73)
|
0.22
|
1.45 (1.01–2.4)
|
1.26 (0.90–1.79)
|
0.08
|
|
Current treatment
| | | | | | |
|
Statin
|
6 (11)
|
8 (14)
|
0.75
|
6 (11)
|
8 (14)
|
0.75
|
|
Insulin
|
1 (2)
|
0 (0)
|
0.99
|
1 (2)
|
0 (0)
|
0.99
|
|
ACE inhibitor
|
6 (11)
|
3 (5)
|
0.51
|
3 (5)
|
6 (11)
|
0.47
|
|
Beta Blocker
|
10 (18)
|
6 (11)
|
0.44
|
9 (16)
|
7 (13)
|
0.82
|
|
Oral antidiabetic
|
2 (4)
|
4 (7)
|
0.66
|
2 (4)
|
4 (7)
|
0.66
|
|
Acute medications
| | | | | | |
|
Gp IIb/IIIa receptor blocker
|
30 (53)
|
23 (41)
|
0.30
|
24 (42)
|
29 (52)
|
0.40
|
|
Antiplatelet
|
48 (84)
|
52 (93)
|
0.25
|
48 (84)
|
52 (93)
|
0.25
|
- ACE = Angiotensin-Converting Enzyme; BMI = Body Mass Index; CABG = Coronary Artery Bypass Graft; CK = Creatine Kinase; CRP = C-Reactive Protein; PCI = Percutaneous Coronary Intervention; SBP = Systolic Blood Pressure; UNL = Upper Normal Limit.
